PMcardio receives FDA Breakthrough Device Designation — read the full story
Powerful Medical
16. June 2023

Powerful Medical Wins the Venture Capital Deal of the Year Award!

We are thrilled to announce that Powerful Medical has been awarded the esteemed title of Venture Capital Deal of the Year at the CVCA & SLOVCA Awards competition. This recognition is a testament to our team’s dedication and the significant strides we’ve made in the past year.

Our sincere gratitude goes to our venture capital partners Venture To Future Fund, bpd partners, and CB ESPRI Impact One, whose faith in our vision and robust support has been instrumental in realising this achievement. Your investment and partnership have fueled our progress, transforming our ambitious vision into innovative solutions that became a reality.

We would also like to extend our appreciation to our esteemed partners, Kinstellar, for their invaluable legal support and Mazars for their thorough due diligence, which contributed greatly to this deal’s success.

While we are deeply honored by this award, we view it not as a final destination but as a significant milestone in our journey. This recognition reaffirms our commitment to our mission: to revolutionize cardiology with the power of AI. It fuels our determination to continue our research and development to ultimately enhance and preserve the lives of cardiac patients around the world.

As we move forward, we remain focused on our goal of expanding our impact and reach. With our incredible team, supportive partners, and a constant drive to innovate, we are excited about what the future holds for Powerful Medical. Here’s to improving lives, one heartbeat at a time. A special thank you goes to our Head of Data, Michal Martoňák, for accepting this award on behalf of the whole team!

To conclude, we would like to thank everyone who supported us along the way.

Powerful Medical

Powerful Medical leads one of the most important shifts in modern medicine by augmenting human-made clinical decisions with artificial intelligence. Our primary focus is on cardiovascular diseases, the world’s leading cause of death.
Powerful Medical leads one of the most important shifts in modern medicine by augmenting human-made clinical decisions with artificial intelligence. Our primary focus is on cardiovascular diseases, the world’s leading cause of death.
About PMcardio:

PMcardio is a CE-certified AI that reads ECGs and offers a complex assessment of 49 cardiac conditions. Clinically validated in 15+ studies and trusted by over 100,000 clinicians, it delivers rapid, expert‑level interpretations, empowering emergency physicians, GPs, nurses, paramedics, and cardiologists to act with confidence at the point of care. Available for Individuals and Organizations.

Share this article

Don't miss these

Image is showing logos of the two companies mentioned in the text - PMcardio and Alphaiota

Alphaiota Expands Strategic Partnership with PMcardio to Launch First AI-Powered Heart Attack Diagnostic Platform in Saudi Arabia

Alphaiota and PMcardio announce the expansion of their strategic partnership to bring the first AI-powered heart attack diagnostic solution to the Kingdom of Saudi Arabia. Developed by Powerful Medical, a medical device manufacturer specializing in AI-driven cardiovascular diagnostics, PMcardio will be introduced by Alphaiota as the exclusive distributor in the region, marking a first-of-its-kind deployment in the Middle East.
Image ilustrating the VAIA grant reception containing logos of important public institutions

Powerful Medical Awarded €1M EU-Funded Grant by Slovak Ministry of Economy to Advance AI-ECG Heart Attack Diagnostics

Powerful Medical has received over €985,000 in funding from the Slovak Ministry of Economy, as part of the EU-funded Recovery and Resilience Plan. The grant supports the continued development of our AI-based ECG interpretation technology, focused on improving early diagnosis and treatment of acute coronary syndromes (ACS).

Join over 100,000 healthcare professionals who are already taking advantage of AI